US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Olanzapine Tablets

Reason cGmp Deviations

Macleods Pharma Usa Inc NDC 33342-070-07 D-0639-2022
Class II · Moderate risk Terminated

Pyrazinamide Tablets

Reason cGMP Deviations

ANI Pharmaceuticals, Inc. NDC 67253-660-10 D-0568-2022
Class II · Moderate risk Terminated

Alprazolam Tablets

Reason cGMP Deviations

ANI Pharmaceuticals, Inc. NDC 67253-903-10 D-0567-2022
Class II · Moderate risk Terminated

Alprazolam Tablets

Reason cGMP Deviations

ANI Pharmaceuticals, Inc. NDC 67253-902-10 D-0566-2022
Class II · Moderate risk Terminated

Alprazolam Tablets

Reason cGMP Deviations

ANI Pharmaceuticals, Inc. NDC 67253-901-10 D-0565-2022
Class II · Moderate risk Terminated

Alprazolam Tablets

Reason cGMP Deviations

ANI Pharmaceuticals, Inc. NDC 67253-900-10 D-0564-2022
Class II · Moderate risk Terminated

Diazepam Oral Solution

Reason Failed Impurities/Degradation Specifications: Out of specification results for related substances.

Lannett Company, Inc. NDC 0527-1768-36 D-0558-2022
Class II · Moderate risk Terminated

Erythromycin Topical Gel USP

Reason Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.

Teligent Pharma, Inc. NDC 63739-053-66 D-0716-2022
Class II · Moderate risk Terminated

Chlorthalidone Tablets USP 25 mg

Reason Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup

Sun Pharmaceutical Industries INC NDC 57664-648-88 D-0578-2022
Class II · Moderate risk Terminated

Prevantics

Reason cGMP deviations: uncertainty of the adequacy of the validation of the test methods used to manufacture the products.

Professional Disposables International, Inc. NDC 10819-4077-1 D-0572-2022
Class II · Moderate risk Terminated

Prevantics

Reason cGMP deviations: uncertainty of the adequacy of the validation of the test methods used to manufacture the products.

Professional Disposables International, Inc. NDC 10819-1080-1 D-0571-2022
Class II · Moderate risk Terminated

Prevantics

Reason cGMP deviations: uncertainty of the adequacy of the validation of the test methods used to manufacture the products.

Professional Disposables International, Inc. NDC 10819-4076-4 D-0570-2022
Class II · Moderate risk Terminated

Cystex Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. D-0555-2022
Class II · Moderate risk Terminated

DBI Magnums Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-941-00 D-0554-2022
Class II · Moderate risk Terminated

Coated Back Relief Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-800-00 D-0553-2022
Class II · Moderate risk Terminated

Legatrin

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-785-00 D-0552-2022
Class II · Moderate risk Terminated

Back Relief II

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-740-00 D-0551-2022
Class II · Moderate risk Terminated

Pain Aid PMF Caplet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-710-00 D-0550-2022
Class II · Moderate risk Terminated

Normed Fem Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-701-00 D-0549-2022
Class II · Moderate risk Terminated

APAP 325 mg

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-700-00 D-0548-2022
Class II · Moderate risk Terminated

Migrenol Caplet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-565-00 D-0547-2022
Class II · Moderate risk Terminated

Phenylephrine HCl 5 mg Tablet

Reason CGMP Deviations

ULTRAtab Laboratories, Inc. NDC 62959-333-00 D-0545-2022